Program record · Telehealth · estradiol patch with progesterone included
Alloy bills the estradiol patch with progesterone included at $224.97 for a 12-week supply, which is $81.52 a month across the cycle. A $49.95 consultation is charged once with the first order and there is no recurring membership.
1 offer · Source read Oct 23, 2026
Read from the provider's own pricing page · standard rate, no promotional pricing.
One row per offer. The charge stays as billed, and the monthly equivalent is derived and labeled as derived.
Estradiol patch with progesterone
Transdermal patch plus oral capsule
Billed together: $224.97 first 12-week supply + $49.95 consultation.
How the billing works
Medication is not billed monthly: it ships quarterly at $224.97 for a 12-week supply. The consultation is billed once, with the first order.
Where the record stops
The consultation is a one-time charge. It appears in the first payment and is left out of the monthly figure, because spreading a single charge across every month would overstate the months after it. Medication is not billed monthly, it ships quarterly, so the record stores the quarterly charge.
Sourcing
Published in full rather than collapsed. A record is only as citable as the rows behind it, including the rows that establish nothing.
6 source rows · every row dated
Charge as billed
Reported$224.97 for a 12-week supply. The record stores the quarterly charge rather than a pre-divided monthly figure.
myalloy.comRead Oct 23, 2026
Billing cadence
ReportedMedication ships and bills quarterly. The terms describe an auto-renewing subscription but do not state the length of the period.
Provider pricing pageRead Oct 23, 2026
Progesterone
ReportedIncluded at no extra cost when prescribed with estradiol. Billed separately only if ordered on its own or added later.
Provider pricing pageRead Oct 23, 2026
Consultation
Reported$49.95 once, covering the intake review and unlimited messaging. Not refundable if the patient is ineligible. No recurring membership.
myalloy.com/terms-of-useRead Oct 23, 2026
Dispensing pharmacies
ReportedThe terms name Curexa Pharmacy in Egg Harbor Township, New Jersey; BLEND Pharmacy in Columbus, Ohio; and Gogo Pharmacy in Southgate, Kentucky. Their state licences are not published.
myalloy.com/terms-of-useRead Oct 23, 2026
State coverage
Not establishedThe terms limit the service to states where it is available without listing them. Review sites claim all 50 states plus D.C., which is not confirmed by the provider.
myalloy.com/terms-of-useRead Oct 23, 2026
A field with no published answer reads not established. It is never shown as a dash, because a dash is where a zero usually hides.
Billed with Estradiol patch and Progesterone inside one offer.
The terms state the service is limited to states where it is available. No coverage list is published, so coverage is recorded as not published.
Commitment, cancellation and refund wording above is quoted as Alloy published it on Oct 23, 2026. It is not a statement of a legal entitlement: auto-renewal and cancellation rules differ by state, and the provider can change its terms after that date.
Nothing here is medical advice. Whether a treatment is appropriate is a decision for a licensed clinician. These terms describe a payment, not whether a treatment is appropriate for anyone.
How this is funded
No program pays for a position here, and no outbound link carries a referral commission. That is a flag in the data rather than a sentence in the copy: if either ever changes, every page that shows this notice discloses it automatically.
Score
The published total is out of 100, but 75 of those points are the same for every listed record. They are the inclusion baseline, not something this program earned. The informative figure is the detail points on top of that baseline, out of 25, earned across five published components: price level, price completeness, required fees priced, terms on record, and whether dose and coverage are stated. It measures how completely the charges are published, not clinical quality, effectiveness, safety or medical endorsement, and no editorial mark is applied.
Disclosure detail earned
20.9of 25
75 of the 95.9 is the fixed inclusion baseline shared by every listed record. The remaining 20.9 is what this record earned on the five components below.
The five components that earn those 25 points
The lowest all-in monthly equivalent the record can derive. Full marks at or below $75, none at or above $400, linear between. No marks at all where the all-in figure is withheld.
The share of a program's offers that carry a derivable all-in monthly figure. The heaviest single weight, because a published all-in price for every offer sold is the thing this index measures.
The share of a program's offers where no required consultation, lab, membership or startup fee is left without an amount.
Two for stating that there is no minimum term, one for stated cancellation terms, one for a membership stated as a number. A stated lock-in earns nothing here.
One for stating whether the charge varies by dose, one for recording where the program ships.
This score measures pricing disclosure completeness. It is not a measure of clinical quality, effectiveness or safety, and it is not a medical endorsement of any program.
Labs included
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Follow-ups included
The sources read establish the opposite of this statement at the check date.
Checked Oct 23, 2026
No separate membership
No membership is billed on top of the medication charge, or a stated membership is already inside it.
Checked Oct 23, 2026
Flat across dose
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Month to month
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Compounded available
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
FDA-approved only
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Ships to all 50 states
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Each line records what the sources established on the check date. A verified line is a finding, a verified-not-met line is the opposite finding, and a not-verified line means the source did not say. A criterion is not a ranking and not a mark of quality.
Last modified Oct 23, 2026